approval
saveEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE) — FDA approval
community read0 votes
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalDAPAGLIFLOZIN: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalApr 6, 2026
- approvalDAPAGLIFLOZIN: DAPAGLIFLOZIN — FDA approvalApr 6, 2026
- approvalMEXILETINE HYDROCHLORIDE: MEXILETINE HYDROCHLORIDE — FDA approvalMar 23, 2026
- approvalMOXIFLOXACIN HYDROCHLORIDE: MOXIFLOXACIN HYDROCHLORIDE — FDA approvalMar 2, 2026
- approvalDILTIAZEM HYDROCHLORIDE: DILTIAZEM HYDROCHLORIDE — FDA approvalFeb 27, 2026
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
🐶 often sniffed alongside
top 6- drugEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE12 co-mentions · 3 sources
- drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE12 co-mentions · 3 sources
- tagApproval12 co-mentions · 3 sources
- tagSmall Molecule6 co-mentions · 3 sources
- drugtenofovir alafenamide4 co-mentions · 2 sources
- drugTENOFOVIR DISOPROXIL FUMARATE2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that